[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Hemophilia Treatment Drugs Market Research Report Forecast 2017 to 2022

June 2017 | 109 pages | ID: C2C1164F57DEN
S&P Consulting

US$ 2,480.00 US$ 3,100.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The China Hemophilia Treatment Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Hemophilia Treatment Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Hemophilia Treatment Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Pfizer
Biotest
CSL Behring
Kedrion
Octapharma
Shire
Novo Nordisk
Bayer
F. Hoffmann-La Roche

China Hemophilia Treatment Drugs Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
China Hemophilia Treatment Drugs Market: Application Segment Analysis
Hemophilia A
Hemophilia B
Others

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 HEMOPHILIA TREATMENT DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Hemophilia Treatment Drugs
1.2 Hemophilia Treatment Drugs Market Segmentation by Type
  1.2.1 China Production Market Share of Hemophilia Treatment Drugs by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Hemophilia Treatment Drugs Market Segmentation by Application
  1.3.1 Hemophilia Treatment Drugs Consumption Market Share by Application in 2016
  1.3.2 Hemophilia A
  1.3.3 Hemophilia B
  1.3.4 Others
1.4 China Market Size Sales (Value) and Revenue (Volume) of Hemophilia Treatment Drugs (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON HEMOPHILIA TREATMENT DRUGS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Hemophilia Treatment Drugs Industry

CHAPTER 3 CHINA HEMOPHILIA TREATMENT DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 China Hemophilia Treatment Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 China Hemophilia Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Hemophilia Treatment Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Hemophilia Treatment Drugs Market Competitive Situation and Trends
  3.5.1 Hemophilia Treatment Drugs Market Concentration Rate
  3.5.2 Hemophilia Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA HEMOPHILIA TREATMENT DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Hemophilia Treatment Drugs Capacity, Production and Growth (2012-2017)
4.2 China Hemophilia Treatment Drugs Revenue and Growth (2012-2017)
4.3 China Hemophilia Treatment Drugs Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA HEMOPHILIA TREATMENT DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Hemophilia Treatment Drugs Production and Market Share by Type (2012-2017)
5.2 China Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Hemophilia Treatment Drugs Price by Type (2012-2017)
5.4 China Hemophilia Treatment Drugs Production Growth by Type (2012-2017)

CHAPTER 6 CHINA HEMOPHILIA TREATMENT DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Hemophilia Treatment Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA HEMOPHILIA TREATMENT DRUGS MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Biotest
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 CSL Behring
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Kedrion
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Octapharma
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Shire
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Bayer
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 F. Hoffmann-La Roche
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 HEMOPHILIA TREATMENT DRUGS MANUFACTURING COST ANALYSIS

8.1 Hemophilia Treatment Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemophilia Treatment Drugs

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hemophilia Treatment Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA HEMOPHILIA TREATMENT DRUGS MARKET FORECAST (2017-2022)

12.1 China Hemophilia Treatment Drugs Production, Revenue Forecast (2017-2022)
12.2 China Hemophilia Treatment Drugs Production, Consumption Forecast by Regions (2017-2022)
12.3 China Hemophilia Treatment Drugs Production Forecast by Type (2017-2022)
12.4 China Hemophilia Treatment Drugs Consumption Forecast by Application (2017-2022)
12.5 Hemophilia Treatment Drugs Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Treatment Drugs
Figure China Production Market Share of Hemophilia Treatment Drugs by Type in 2016
Table Hemophilia Treatment Drugs Consumption Market Share by Application in 2016
Figure China Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Table China Hemophilia Treatment Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2015
Figure China Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2016
Table China Hemophilia Treatment Drugs Production of Key Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Treatment Drugs Production Share by Manufacturers
Figure 2016 Hemophilia Treatment Drugs Production Share by Manufacturers
Table China Hemophilia Treatment Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table 2016 China Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table China Market Hemophilia Treatment Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Hemophilia Treatment Drugs Average Price of Key Manufacturers in 2016
Table Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemophilia Treatment Drugs Product Type
Figure Hemophilia Treatment Drugs Market Share of Top 3 Manufacturers
Figure Hemophilia Treatment Drugs Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Hemophilia Treatment Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Hemophilia Treatment Drugs Market Share (2012-2017)
Table Biotest Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotest Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Biotest Hemophilia Treatment Drugs Market Share (2012-2017)
Table CSL Behring Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CSL Behring Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table CSL Behring Hemophilia Treatment Drugs Market Share (2012-2017)
Table Kedrion Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kedrion Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Kedrion Hemophilia Treatment Drugs Market Share (2012-2017)
Table Octapharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Octapharma Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Octapharma Hemophilia Treatment Drugs Market Share (2012-2017)
Table Shire Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Shire Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Shire Hemophilia Treatment Drugs Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Hemophilia Treatment Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Hemophilia Treatment Drugs Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Market Share (2012-2017)
Figure Production Revenue Share of Hemophilia Treatment Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Hemophilia Treatment Drugs by Type
Table China Hemophilia Treatment Drugs Price by Type (2012-2017)
Figure China Hemophilia Treatment Drugs Production Growth by Type (2012-2017)
Table China Hemophilia Treatment Drugs Consumption by Application (2012-2017)
Table China Hemophilia Treatment Drugs Consumption Market Share by Application (2012-2017)
Figure China Hemophilia Treatment Drugs Consumption Market Share by Application in 2016
Table China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Treatment Drugs
Figure Manufacturing Process Analysis of Hemophilia Treatment Drugs
Figure Hemophilia Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015
Table Major Buyers of Hemophilia Treatment Drugs
Table Distributors/Traders List
Figure China Hemophilia Treatment Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Hemophilia Treatment Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Hemophilia Treatment Drugs Production Forecast by Type (2017-2022)
Table China Hemophilia Treatment Drugs Consumption Forecast by Application (2017-2022)


More Publications